Skip to main content

Home›Research›Compare›Endoluten vs MOTS-c

Peptide Comparison

Endoluten vs MOTS-c

Both are Longevity & Cellular peptides.

Endoluten

pineal peptide bioregulator

LongevityResearch Only

1 providers listed

Full Endoluten profile →
vs

MOTS-c

Mitochondrial ORF of the 12S rRNA type-c

LongevityAdvisory Vote: FavorableResearch Only

Half-life: Unknown (rapidly cleared from plasma)

242 providers listed

Full MOTS-c profile →
Bottom line

MOTS-c carries stronger published evidence (Cohort study, 8 key studies) than Endoluten (Review, 1); both are research compounds.

Quick Verdict

Endoluten

MOTS-c

Which One Should You Choose?
Your goalBetter option
Stronger clinical evidenceMOTS-c
Oral administration optionEndoluten
More provider options (1 vs 242)MOTS-c

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison
Endoluten
MOTS-c
Mechanism Family
Longevity & Cellular
Longevity & Cellular
Half-life
—
Unknown (rapidly cleared from plasma)
FDA Status
unknown
advisory committee recommended
Admin Routes
oral, subcutaneous
subcutaneous, intravenous
Availability
Research Only
Research Only
Providers
1 listed
242 listed
FDA Update
—
Jul 2026
Avail. Notes
—
Mitochondria-derived peptide encoded in 12S rRNA. Regulates metabolism and exercise capacity. No FDA approval, no NDA or IND. Pure research compound; no clinical development program.
Research Evidence

Endoluten

Review · 1 key study · dated evidence base — most recent 2002

MOTS-c

Cohort study · 8 key studies · most recent 2026
Research Citations

About Endoluten

Pineal-targeted peptide complex that modulates melatonin synthesis pathways and circadian gene expression. May help restore age-related decline in pineal activity and improve circadian rhythm regulation.

Research Areas
circadian rhythm supportmelatonin pathwaysleep qualitylongevityanti-aging

About MOTS-c

Mitochondria-derived peptide that translocates to nucleus under stress; activates AMPK pathway, regulates AICAR and folate-methionine cycle

Research Areas
metabolic regulationinsulin sensitivityexercise mimicryanti-aging
Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Endoluten

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

MOTS-c

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Price (per mg)

Endoluten

Not enough vendor pricing yet.

MOTS-c

$4.00/mg

$3.00 – $6.00 range

82 vendors

Find Providers

Where to source these peptides

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Longevity & Cellular Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated October 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Endoluten vs MOTS-c — Per-mg Price Comparison. Retrieved October 27, 2026, from https://peptidebase.io/peptides/compare/endoluten/mots-c

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.